All procedures were reviewed and approved by the Virginia Tech Institutional Review Board (#23460)
During the three-year shortage period, Hims & Hers, along with many other companies, began selling a compounded version of the drug, capturing profits that would be typically foreclosed by competitor Novo Nordisks patents
It's a website that links cash-paying patients to discounted manufacturer prices
In September 2025, the FDA also issued a Since medical services are confidential, Hers says customer reviews arent available for all of its products and services
Distinguishing semaglutide-related anxiety from weight-loss-induced stress (social anxiety about body changes) requires honest assessment of your baseline anxiety history
During an initial healing phase, run higher doses of healing peptides